Efficacy and safety of atorvastatin and pravastatin in patients with hypercholesterolemia

This publication has 28 references indexed in Scilit:

• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.
  The American Journal of Cardiology, 1998
• Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)
  The American Journal of Cardiology, 1995
• Fluvastatin with and without niacin for hypercholesterolemia
  The American Journal of Cardiology, 1994
• Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors
  The American Journal of Cardiology, 1993
• Efficacy and safety of pravastatin in patients with primary hypercholesterolemia
  Atherosclerosis, 1990
• New Horizons in Combination Drug Therapy for Hypercholesterolemia
  Cardiology, 1989
• Lovastatin
  Drugs, 1988
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987